Introduction
Invasive mould diseases (IMD) are the main cause of fungal disease in immunocompromised patients with haematological disorders. In epidemiological and therapeutic studies, IMD are diagnosed according to consensus criteria defined by the European Organization for Research and Treatment of Cancer/Mycosis Study Group (EORTC/MSG). 1 These criteria include the recovery of a mould in cultures of non-sterile specimens such as sputum, broncho-alveolar lavage fluid, bronchial brush or sinus aspirates. Such samples are easily obtained and can lead to the diagnosis of probable IMD. 1 The EORTC/MSG criteria do not grade the identified mould according to whether it was isolated as a pure colony and/or from repeat samples.
Furthermore, the mould species included in the EORTC/MSG criteria are not clearly defined, although it is usually accepted that only species with known pathogenic potential should be considered when analysing respiratory specimens. This includes Aspergillus, Fusarium, Mucorales and Scedosporium spp., with Aspergillus fumigatus being by far the main species responsible for invasive aspergillosis (IA). [2] [3] [4] Apart from these well-+known pathogenic moulds, other moulds isolated from respiratory specimens are usually deemed at best colonising moulds or irrelevant environmental contaminants. This prevents all further analysis and even the reporting of such moulds.
To challenge this attitude, we analysed the results of mycological cultures of respiratory specimens obtained from haematology patients during routine practice in our laboratory. We identified non-sporulating moulds (NSMs) by sequencing the nuclear ribosomal internal transcribed spacer (ITS) region as consensually proposed. 5 Sequencing can identify putative emergent pathogenic species without a priori. 6 On the other hand, pathogenic moulds without reproductive structures, such as non-sporulating A. fumigatus, 7 may be falsely discarded as contaminants. The goal of this study was to describe the diversity of fungi recovered from cultured respiratory specimens from haematology patients, focusing on non-sporulating moulds. In particular, we sought to determine how often such moulds are isolated pure or in association with other fungi.
Materials and methods

Respiratory specimens
We performed a prospective single-centre hospitalbased study including every sputum and broncho-tracheal aspirate received in our laboratory from June 15, 2010 to December 31, 2011 as part of routine laboratory testing for suspected IMD in the context of pneumonia and/or unexplained fever in patients with haematological malignancies. Most broncho-tracheal aspirates were obtained by bronchoalveolar lavage. Patients were definitively classified into probable IMD or invasive aspergillosis (IA) according to the 2008 EORTC/MSG criteria 1 every 2 months during a multidisciplinary medical meeting. The clinicians were aware of the presence of NSM, but not of the molecular analysis; therefore, our findings did not influence any medical decisions. According to French Public Health Law (CSP Art L1121-1.1), our study protocol required neither the approval of an ethics committee nor informed consent for the use of patient samples.
According to standard practice in our laboratory, following their arrival, respiratory samples were centrifuged and seeded onto (i) one plate containing chromogenic medium (Candiselect 2 BioM erieux, Marcy l'Etoile, France) incubated at 37°C for 1 week, and (ii) two Sabouraud agar slants supplemented with chloramphenicol and gentamicin (Bio-Rad, Marnes la Coquette, France) incubated at 37°C and at 30°C (one at each temperature) for 3 weeks. Cultures were checked daily and each colony was identified using ID32C (BioM erieux) for yeast, and macro and microscopic phenotypic features for moulds according to standard practices. 8 If several colonies were observed, each colony was seeded onto a new plate to obtain pure colonies. In the absence of fructification suggestive of a species or a genus, the colony was categorised as NSM.
DNA extraction, amplification and sequencing
The NSM colony was scraped from the agar slant, transferred to 1 ml of PBS, vortexed for 60 s and then heated for 15 min at 100°C. The suspension was vortexed briefly and then pelleted for 5 min at a maximum speed of 16 000 g in a microcentrifuge. DNA was extracted from the supernatant using the Qiagen DNA Blood kit (QIAgen, Courtaboeuf, France) according to the manufacturer's recommendations. DNA was finally eluted in 50 ll of the elution buffer and quantified using a NanoDrop DN-1000 Spectrophotometer (Fisher Scientific, Illkirch, France).
A total of 10 ng of DNA was amplified for both the ITS1 and ITS2 regions in two independent reactions in a final volume of 50 ll. An M13 tail was added to the ITS primers 9 to standardise the amplification and sequencing parameters (ITS5-M13F:
primer and 1.25 U of Fast Start Taq DNA polymerase (Roche Diagnostics, Meylan, France). After an initial denaturation step at 95°C for 8 min, samples were amplified for 35 cycles of denaturation at 95°C for 30 s, annealing at 52°C for 30 s and extension at 72°C for 1 min, followed by a final extension at 72°C for 5 min. PCR products were visualised on a QIAxcel instrument (QIAgen) and then enzymatically cleaned with shrimp alkaline phosphatase (SAP) and exonuclease I (Exo) to remove un-incorporated dNTPs and primers, respectively. A total of 3 ll of corresponding PCR reaction was incubated with 2 ll of ExoSAP-IT (USB Europe, Staufen, Germany) for 30 min at 37°C followed by 15 min at 80°C to inactivate the enzyme, and was then sequenced bidirectionally using the Dideoxy Terminator Cycle Sequencing Kit v1.1 protocol (Applied Biosystems, Courtaboeuf, France). The reaction products were purified by gel filtration using Sephadex G-50 (Amersham, Courtaboeuf, France), run on an ABI PRISM 3130 Genetic Analyser and analysed with the SEQSCAPE v2.6 software (Applied Biosystems, Courtaboeuf, France).
The obtained sequences were subjected to pairwise alignments against curated fungal reference databases available at the on-line MycoBank database (http:// www.mycobank.org/). In addition, a BLAST search against known sequences in NCBI Genbank was performed. Sequence identities with a cut off ≥ 97% over 450 nucleotides in length were considered significant. The best BLAST hits were those showing the highest percentage similarity for a query coverage of more than 90%. Sequences were aligned with the CLUSTALX (version 1.83) computer program. 10 A distance tree was obtained using MEGA v.5.1 software with the neighbour-joining algorithm and the Kimura twoparameter model with a gamma distribution. Rhizopus arrhizus (CNRMA8.507) and Rhizopus microsporus (UMIP1124.75) were chosen as out-groups, and the robustness of the branches was evaluated by 1000 bootstrap replications.
Results
During the study period, we received 251 respiratory samples (median of two samples/patient; range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] From the 179 positive samples, we classified 287 fungal colonies (142 moulds and 145 yeasts) based on routine examination (Table 1) . We identified 17 yeast genera/species, with Candida albicans and Candida glabrata being the two main species. Based on microscopic features, we identified 11 different genera/species of moulds, with A. fumigatus, Penicillium spp., and NSM being the main species (Table 1) .
We isolated 24 NSMs in total from 19 patients ( Table 2) , 22 of which were identified by ITS sequencing. For the remaining two isolates, we failed to obtain pure colonies and therefore to obtain an analyzable chromatogram (Patients 18 and 19, Table 2 ). Eighteen isolates belonged to the Basidiomycota and six to the Ascomycota (Fig. 1) . All sequences were assigned to the species level except for two basidiomycetes (NSMs 2 and 10), which were only identified to the Table 1 Fungal identification obtained for the 287 isolates upon routine identification. . Globally, NSMs were assigned to 16 different genera/species by sequencing, including three that were detected more than once: Hexagonia hydnoides (n = 3), Bjerkandera adusta (n = 3) and Psathyrella sp (n = 2). Among the Ascomycota, no NSM corresponded to non-sporulating A. fumigatus or any other species usually involved in IMD. Several NSMs were frequently isolated with other moulds or yeast in the same sample (10/24 for other moulds and 6/24 for yeast; Table 2 ). Of note, NSMs were isolated in five patients with probable IA either concomitantly with A. fumigatus (Patients 15 and 17) , or in a subsequent sample (Patients 3, 9 and 17). None of the NSMs were ascribed any specific pathogenic role by clinicians. For the only Mucorales isolate identified (Table 1) , the corresponding patient was not diagnosed with IMD and the isolate was not further investigated. This also applied to the five Fusarium sp isolates, one of which was obtained from a patient without probable IMD and the other four were isolated along with A. fumigatus in patients with probable IA.
Given that no NSM was recovered twice in patients with ≥2 samples, we examined whether this was also true for A. fumigatus. Out of 25 patients (16 probable IAs; nine without IA) with ≥2 samples available and at least one A. fumigatus isolated, 10 had ≥2 A. fumigatus positive samples and six only one (Fisher's exact test, P: 0.097, ns), confirming that A. fumigatus more than twice was not taken into account by the clinicians when classifying the patients according to the EORTC/MSG definitions.
Discussion
Little attention has been paid to the details of the mycological results collected for the diagnosis of IMD. Indeed, neither the number of mould-positive cultures Figure 1 Neighbour-joining tree generated from the internal transcribed spacer (ITS) sequences of the 22 identified non-sporulating moulds listed in Table 2 . Bootstrap values are indicated above the branches. Only values above 70% are shown. The bar indicates the number of substitutions per site. Aspergillus fumigatus isolation on another respiratory sample. 4 Genbank accession number.
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Syn. Hormographiella aspergillata.
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Uncertain identification since no sequence entry for known taxa was available for these strains.
nor the presence of a single mould species recovered in culture are considered in the EORTC/MSG definitions of IMD 1 and are therefore not reported. 2, 4 By focusing specifically on NSMs, we clearly show that the fungal species isolated from respiratory specimens of immunocompromised patients are highly variable, mixtures of culturable species are frequent and reproducibility over serial samples is often lacking. The frequency with which different moulds were isolated from the same sample (10.1%; 18/179) in the present study was probably greatly underestimated, because: (i) some species can interfere with the growth of other species and pure cultures are often difficult to obtain; (ii) we did not identify some isolates at the species levels (e.g. Penicillium spp.); (iii) some of the isolates identified actually belong to complexes of species (e.g. A. niger); and (iv) many species cannot grow on Sabouraud medium. In addition to being frequently mixed, moulds were also very diverse in terms of the species involved. Ten different genera/species of mould were identified morphologically by microscopy and 22 sequenced NSMs were assigned to 16 different genera/ species. An additional advantage of sequencing NSMs is that it can rule out the presence of nonsporulating pathogenic species, such as a non-sporulating A. fumigatus. The epidemiology of IMD in haematology patients has changed in recent years with new populations at risk, such as patients with lymphoproliferative diseases, 2 long-term steroid therapy as the main risk factor 11, 12 and breakthough infections under antifungal prophylaxis. 13 Galactomannan detection tends to be less sensitive in these patients. As a consequence, direct examination and culture are more often the only mycological criteria to assess probable IA. 1 Therefore, the interpretation of cultures of mixed moulds or those containing moulds with no known pathogenic role should be revised in immunocompromised patients investigated for fever or febrile neutropenia. NSMs are often deemed clinically irrelevant because the simplest and most widely accepted explanation for their presence is environmental contamination. However, some NSMs from the basidiomycetes 14 as well as hyalo-and phaeohyphomycosis 15 are now thought to be potential pathogens.
A common although unproven criterion to ascribe a pathogenic role to a new species, is the recovery of the same species in serial samples, 8 with the hypothesis that persistent species are more likely to be pathogenic. Whether a NSM was isolated more than once is rarely specified in case reports for unusual or newly reported species.
14 In our study, we did not grow NSMs of the same species in samples from the same patient more than once, which argues against the perennial presence of the species in the respiratory tract. However, persistent isolation of A. fumigatus from patients with a final diagnosis of probable IA was not observed in our population either. Moreover, it remains impossible to determine whether a cultivable A. fumigatus was recently acquired or is a long-term resident of the bronchi with higher pathogenic potential. Even with well-established genotyping methods and extensive sampling, the timing of acquisition of A. fumigatus cannot be elucidated 16, 17 and that would be probably the same for NSMs.
An argument for considering NSMs in immunocompromised patients is the results of next generation sequencing (NGS). This technology shows that the association of several moulds is the rule in respiratory specimens and not the exception, with the coining of the term 'mycobiome'. 18, 19 The mycobiome should be explored in immunocompromised patients with haematological disorders, as reported for asthma, 20 cystic fibrosis patients 21 and lung transplant recipients. 22 Currently, the main advantage of cultures over NGS, besides the lower cost and workload, is that cultures select viable moulds and not only DNA, which, on the other hand, can introduce bias in the analysis of species diversity.
The isolation of non-aspergillus moulds in respiratory specimens from haematology patients should be accorded the same significance as yeast is in some centres. Indeed, although some authors did not find any correlation between Candida and death from pneumonia, 23 others found that Candida either limits, 24 or promotes 25 bacterial lung injury. The isolation of several moulds could thus be considered an indirect sign of an altered respiratory epithelium, as imbalance in the intestinal mycobiome is thought to play a role in gastro-intestinal graft-vs.-host disease. 26 Alterations of the respiratory epithelium may also increase the risk of A. fumigatus conidia being trapped in the bronchi. Additionally, some non-fumigatus moulds may be involved in asthma or chronic cough, which can also indicate altered or sensitised bronchi. 14 In conclusion, the fungi present in respiratory specimens of immunocompromised patients are very diverse and can be regarded as part of a mycobiome. Changes to this mycobiome over time should be considered more clinically relevant than the isolation of a particular species at a given time. In future epidemiological studies on IA (at least until more studies investigating the pulmonary mycobiome in patients with respiratory diseases are performed), the number of samples yielding A. fumigatus colonies and the presence of other moulds should be specified. This may help us to understand, at least in part, the involvement of nonaspergillus species in these patients. Protocols should be established to define the number of respiratory samples and all identified fungi should be declared. This will also help to understand the significance of the galactomannan detection in respiratory specimens since several fungal species can produce this antigen.
